Finerenone in Hispanic Patients With CKD and Type 2 Diabetes: A Post Hoc FIDELITY Analysis

Finerenone in Hispanic Patients With CKD and Type 2 Diabetes: A Post Hoc FIDELITY Analysis

Rationale & Objective: In FIDELITY, finerenone improved cardiorenal outcomes in patients with chronic kidney disease (CKD) and type 2 diabetes. This analysis explores the efficacy and safety of finerenone in Hispanic patients. Study Design: Post hoc analysis of the FIDELITY prespecified pool...

Full description

Bibliographic Details
Main Authors: Sylvia E. Rosas, Luis M. Ruilope, Stefan D. Anker, Bertram Pitt, Peter Rossing, Andres Angelo Cadena Bonfanti, Ricardo Correa-Rotter, Fernando González, Carlos Francisco Jaramillo Munoz, Pablo Pergola, Guillermo E. Umpierrez, Andrea Scalise, Charlie Scott, Robert Lawatscheck, Amer Joseph, George L. Bakris
Format: Article
Language:English
Published: Elsevier 2023-10-01
Series:Kidney Medicine
Subjects:
Type 2 diabetes
chronic kidney disease
cardiorenal
Hispanic patients
finerenone
nonsteroidal mineralocorticoid receptor antagonist
Online Access:http://www.sciencedirect.com/science/article/pii/S259005952300122X

Internet

http://www.sciencedirect.com/science/article/pii/S259005952300122X

Similar Items